Allogeneic Hematopoietic Stem Cell Transplantation for Intermediate Cytogenetic Risk AML in First CR

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2012.84
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Achieving Stringent CR Is Essential Before Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in AML

Bone Marrow Transplantation
TransplantationHematology
2013English

Pulmonary Tuberculosis in Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2001English

Risk Factors for Acute Kidney Injury in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Chinese Journal of Cancer
2010English

Chimerism Monitoring Following Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2007English

Outcomes of Lung Transplantation After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Second Allogeneic Hematopoietic Stem Cell Transplantation as Treatment for Leukemia Relapsing Following a First Transplant

Bone Marrow Transplantation
TransplantationHematology
2000English

Kaposi's Sarcoma Developed After Allogeneic Hematopoietic Stem Cell Transplantation

Oncology Letters
Cancer ResearchOncology
2011English

CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy